This activity series presents the common challenges of diagnosing and managing progressive fibrotic interstitial lung disease subtypes of IPF and SSc-ILD . There is at present no cure for IPF or SSc-ILD and existing treatments focus on delaying disease progression, controlling symptoms and preventing complications.

Optimizing the Diagnosis and Management Through Multi-Disciplinary, Patient-Centered Care

This CME activity reviews the mechanism of action, efficacy, and safety of targeted agents approved for the management of severe, uncontrolled asthma with Type 2 inflammation and those in late-stage development.

This case-based enduring activity will cover the long-term treatment and management of patients with psoriasis.

Differentiate IPF from other interstitial lung diseases through comprehensive assessment, diagnosis, and/or referral to ILD specialty centers.

Diagnose interstitial lung diseases (ILDs) in a timely manner through optimal use of diagnostic criteria and radiologic findings